LINDSAY FEHRING: Open Payments
NPI 1184347700 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,688 in 53 payments from 18 companies in 2025. Trend: 2023 $590 · 2024 $2,916 · 2025 $1,688
Food & beverage: $1,383Consulting: $305
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $329 |
| Becton, Dickinson and Company | 1 | $305 |
| Mallinckrodt Hospital Products Inc. | 2 | $268 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $170 |
| PFIZER INC. | 7 | $122 |
| ABBVIE INC. | 7 | $113 |
| GENZYME CORPORATION | 3 | $67 |
| Madrigal Pharmaceuticals | 4 | $62 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| QOL Medical, LLC | 2 | $37 |
Products named: TREMFYA, TERLIVAZ, ENTYVIO, RINVOQ, DUPIXENT, VELSIPITY, REZDIFFRA, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
